Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

For resources on COVID-19 as it applies to the oncology community, please visit ACCC’s continually updated Coronavirus Resource page. ACCC members can also access ACCCExchange, a listserv that allows them to communicate in real time with their colleagues about how the COVID-19 virus is affecting their communities and their patients. As COVID-19 spreads across the U.S., not everyone will get sick. …
For most providers and other professionals in the healthcare industry, information about coronavirus (COVID-19) is coming fast and furious. As we strive to flatten the curve of the spread of the virus, a "new normal" of patient care delivery has for many of us materialized seemingly overnight. Our workdays are likely getting busier, and our home lives more complicated. It’s getting more and more difficult …
Presented by: The Angeles Clinic & Research Institute & ACCC February 5, 2020 Advanced Cutaneous Squamous Cell Carcinoma: Immuno-Oncology and the Evolving Landscape of Multidisciplinary Care Speakers Omid Hamid, MD Chief, Translational Research and Immunotherapy Director, Melanoma Therapeutics Angeles Clinic & Research Institute Santa Monica, CA …
SCOS Fellows Travel Award The South Carolina Oncology Society (SCOS) is committed to supporting the educational needs of its Fellows and Residents, who are vital to the future of delivering high-quality patient care across South Carolina. The SCOS Board of Directors are pleased to announce the SCOS Fellow/Resident Travel Award, which has been created to help offset travel expenses for SCOS Fellows …
The topic of drug waste is nothing new in healthcare. Over the years, reports have surfaced attempting to put a dollar amount on this waste. In 2017, the Centers for Medicaid and Medicare Services began requiring all physicians, hospitals, and other providers submitting Medicare Part B drug claims to report any discarded amount of a single use vial or other single use package drug on its claim for …
Microsoft Word - Guidance for Cancer Programs.docx Guidance for Cancer Programs During the Coronavirus Outbreak From Jennie R. Crews, MD, MMM, FACP Medical Director, Seattle Cancer Care Alliance Network; ACCC Past President • Take social distancing seriously. • Formulate your policies and procedures now on testing algorithms. • Establish testing locations such as …
BY ELECTRONIC DELIVERY Patricia Flatley Brennan, RN, PhD National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894 RE: Request for Information (RFI), ClinicalTrials.gov Modernization Dear Director Brennan: On behalf of the 15 undersigned organizations, we welcome your request for our input on the efforts of the National Library of Medicine (NLM) on behalf …
Pandemic Planning Clinical Guideline for Patients with Cancer March 10 2020 2 Pandemic Planning Clinical Guideline for Patients with Cancer Contents INTRODUCTION .................................................................................................. 4 Planning Assumptions …
Guidance for Cancer Programs Guidance for Cancer Programs During the Coronavirus Outbreak From Jennie R. Crews, MD, MMM, FACP Medical Director, Seattle Cancer Care Alliance Network; ACCC Past President • Take social distancing seriously. • Formulate your policies and procedures now on testing algorithms. • Establish testing locations such as drive-through screenings. • Screen …
ACCC collaborated with the American Cancer Society Cancer Action Network and 13 other stakeholder organizations in a collaborative letter responding to ClinicalTrials.gov's request for information to guide their modernization process. Read the Letter
“In this town, we’ve seen healthcare become a political lightning rod,” U.S. Senator Debbie Stabenow (D-MI) told attendees on March 5 at the ACCC 46th Annual Meeting & Cancer Center Business Summit (AMCCBS) in Washington, D.C. As our nation grapples with unprecedented challenges—both individually and collectively—posed by the world-wide novel COVID-19 outbreak, it seems as though lightning has …
AACR Panel on Racism and Racial Inequalities in Cancer Research: Let It Not Be in Vain At the American Association for Cancer Research (AACR) Virtual Annual Meeting in June a special session hosted by AACR President Antoni Ribas, MD, PhD, FAACR, brought together a distinguished panel of leaders from academia, government, industry, and the patient advocacy community for a frank conversation on racism …
Legal Perspective: Clinical Trial Flexibilities Granted During COVID-19 During the COVID-19 Public Health Emergency, the U.S. Food and Drug Administration (FDA) granted some flexibilities for the conduct of clinical trials of medical products to help mitigate the impact of the pandemic on clinical studies and study participants. For perspective on what the landscape may look like post-pandemic, ACCC …
Patient Advocacy in Clinical Research Carla Strom, MLA, assistant director of operations in the Office of Cancer Health Equity at Wake Forest Baptist Comprehensive Cancer Center and a two-time young adult cancer survivor, discusses how her role as a patient advocate has evolved and why listening to the community voice early and often in research is vital.
 Read Full Article Carla Strom, MLA, is …
What Works Best in the Real World? Research studies on cancer prevention and screening provide evidence on efficacy of interventions. Clinical guidelines, USPSTF recommendations, and guidance from professional societies establish criteria for whom to screen and when. Implementation science research assesses how best to integrate these interventions into healthcare practice. Read Full Article Implementation …
Featured Clinical Research: The Impact of COVID-19 on Minority Communities In June, the New England Journal of Medicine published a study by Eboni G. Price-Haywood, MD, MPH, and colleagues, Hospitalization and Mortality among Black Patients and White Patients with Covid-19, that examined EHR patient data from Ochsner Health, an integrated healthcare delivery system, between March 1 and April 11, …
Closing Gaps – Building Trust in Clinical Trials for Our Communities Highlights from an FDA Oncology Center of Excellence panel discussion around improving clinical trial participation among historically under-represented patient populations. Experts suggest strategies like use of technology to help overcome implicit bias, hosting community events like host “Facts and Faith Friday,” and more. Read …
Sexual and Gender Minority Representation in Clinical Research: A Message from the President's Task Force With this issue, the ACCC Research Review looks at how community oncology can begin to address a significant gap in cancer research—knowledge and information on care for sexual and gender minority (SGM) patients with cancer. Recognition of the myriad inequities in care access, screening, …
Clinical Trials and AYAs: Listening and Learning By Krista Nelson, MSW, LCSW, OSW-C, BCD Krista Nelson is Program Manager Quality and Research, Cancer Support Services and Compassion, Providence Cancer Institute in Portland, Oregon. She defines her role as providing support for people and their families throughout the cancer continuum and sharing the expertise that she has learned from other patients …
Training for the Clinical Trials Workforce: A Message from the President's Task Force By Al B. Benson III, MD, FACP, FASCO This edition of the ACCC Research Review focuses on issues related to workforce training for cancer clinical research. Whether a cancer program is currently conducting clinical studies or is considering becoming a trial site, the bedrock on which all training rests is an understanding …